Dan Ives, Global Head of Technology Research at Wedbush Securities, talks about how Deepseek has transformed China's role in ...

Day One Biopharmaceuticals (NASDAQ:DAWN – Get Free Report)‘s stock had its “outperform” rating reissued by equities research ...

In a report released today, Daniel Ives from Wedbush maintained a Buy rating on C3ai (AI – Research Report), with a price target of $45.00. The ...

Dan Ives, Managing Director and Senior Equity Analyst at Wedbush Securities, shares his expert insights on the future of AI, ...

Wedbush analyst Daniel Ives maintained a Buy rating on Pegasystems (PEGA – Research Report) today and set a price target of $125.00. The ...

Wedbush Securites, a 70-year-old financial services firm based in Los Angeles, has filed with the Securities and Exchange ...

If the Department of Defense goes through budget cuts as suggested by a leaked memo, Palantir Technologies (PLTR) would have ...

Analysts at Wedbush issued their FY2029 earnings per share estimates for Aerovate Therapeutics in a research report issued to clients and investors on Monday, February 24th. Wedbush analyst L. Chico ...

Since its founding in 1955, Wedbush is widely known for providing clients, both private and institutional, with a wide range of securities brokerage, clearing, wealth management, and investment ...

Super Micro Computer Inc. on Tuesday afternoon filed audited financials with the Securities and Exchange Commission, sending ...